Compare VLO & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VLO | IDXX |
|---|---|---|
| Founded | 1980 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.2B | 57.1B |
| IPO Year | 1997 | 1996 |
| Metric | VLO | IDXX |
|---|---|---|
| Price | $226.00 | $583.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 10 |
| Target Price | $221.59 | ★ $706.00 |
| AVG Volume (30 Days) | ★ 3.4M | 433.1K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | 7.57 | ★ 13.08 |
| Revenue | ★ $122,687,000,000.00 | $4,303,702,000.00 |
| Revenue This Year | $9.62 | $10.88 |
| Revenue Next Year | N/A | $8.59 |
| P/E Ratio | ★ $29.81 | $44.48 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $110.00 | $424.48 |
| 52 Week High | $258.43 | $769.98 |
| Indicator | VLO | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 50.16 |
| Support Level | $161.94 | $558.15 |
| Resistance Level | $258.43 | $657.26 |
| Average True Range (ATR) | 8.12 | 14.48 |
| MACD | -3.31 | 3.70 |
| Stochastic Oscillator | 29.41 | 63.80 |
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.